sorafenib has been researched along with granisetron in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (granisetron) | Trials (granisetron) | Recent Studies (post-2010) (granisetron) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 59 | 0 | 16 |
Protein | Taxonomy | sorafenib (IC50) | granisetron (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 4.3 | |
D | Rattus norvegicus (Norway rat) | 3.8019 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 3.8019 | |
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 1.76 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.7702 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 5 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 1.76 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for sorafenib and granisetron
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |